Translational mapping of spatially resolved transcriptomes in human and mouse pulmonary fibrosis

• Published in: bioRxiv
• Main Authors: Franzén, Lovisa, Martina Olsson Lindvall, Hühn, Michael, Ptasinski, Victoria, Setyo, Laura, Benjamin, Keith, Collin, Astrid, Oag, Steven, Volckaert, Thomas, Borde, Annika, Lundeberg, Joakim, Lindgren, Julia, Belfield, Graham, Jackson, Sonya, Ollerstam, Anna, Stamou, Marianna, Ståhl, Patrik L, Hornberg, Jorrit J
• Format: Paper
• Language: English
• Published: Cold Spring Harbor Cold Spring Harbor Laboratory Press 21.12.2023
• Subjects: Alveoli; Apolipoprotein E; Bleomycin; Epithelial cells; Fibrosis; Gene mapping; Lung diseases; Microenvironments; p53 Protein; Pulmonary fibrosis; Transcriptomes
• DOI: 10.1101/2023.12.21.572330

Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with poor prognosis and limited treatment options. Efforts to identify effective treatments are thwarted by limited understanding of IPF pathogenesis and poor translatability of available preclinical models. To address these limitations, we generated spatially resolved transcriptome maps of human IPF and bleomycin-induced mouse lung fibrosis. We uncovered distinct fibrotic niches in the IPF lung, characterized by aberrant alveolar epithelial cells in a microenvironment dominated by TGFβ signaling alongside factors such as p53 and ApoE. We also identified a clear divergence between the arrested alveolar regeneration in the IPF fibrotic niches, and the active tissue repair in the acutely fibrotic mouse lung. Our study offers in-depth insights into the IPF transcriptional landscape and proposes alveolar regeneration as a promising therapeutic strategy for IPF.Competing Interest StatementP.L.S. and J.L. are scientific consultants to 10x Genomics. All other authors are employees at AstraZeneca and may hold shares in the company.